Abiopharma

Treace John T. 🔴 sold 13.2K shares of TREACE MEDICAL CONCEPTS, INC. (TMCI) Transaction Date: Jan 10, 2026 | Filing ID: 012080

Burrows Scott L 🟢 acquired 140.0K shares (1 derivative) of Spyre Therapeutics, Inc. (SYRE) at $30.61 ($4.3M) Transaction Date: Jan 09, 2026 | Filing ID: 000004

Director Turtle Cameron 🟢 acquired 528.0K shares (1 derivative) of Spyre Therapeutics, Inc. (SYRE) at $30.61 ($16.2M) Transaction Date: Jan 09, 2026 | Filing ID: 000003

Sloan Sheldon 🟢 acquired 140.0K shares (1 derivative) of Spyre Therapeutics, Inc. (SYRE) at $30.61 ($4.3M) Transaction Date: Jan 09, 2026 | Filing ID: 000002

New Form S-1MEF - BriaCell Therapeutics Corp. Filed: 2026-01-13 AccNo: 0001493152-26-002103 Size: 362 KB

Heery Christopher 🟡 adjusted position in 9.1K shares of Arcellx, Inc. (ACLX) at $65.51 Transaction Date: Jan 13, 2026 | Filing ID: 012077

Director Rich Stuart 🟢 acquired 875.3K shares (6 derivative) of TENAX THERAPEUTICS, INC. (TENX) at $2,848.00 ($10.5M) Transaction Date: Jan 09, 2026 | Filing ID: 000001

Director PROEHL GERALD T 🟢 acquired 198.3K shares (9 derivative) of TENAX THERAPEUTICS, INC. (TENX) at $9,968.00 ($1.6M) Transaction Date: Jan 09, 2026 | Filing ID: 000001

Director Congleton Jon 🔴 sold 16.2K shares of Mineralys Therapeutics, Inc. (MLYS) at $33.15 Transaction Date: Jan 12, 2026 | Filing ID: 000002

Levy Adam Scott 🔴 sold 10.8K shares of Mineralys Therapeutics, Inc. (MLYS) at $32.14 Transaction Date: Jan 12, 2026 | Filing ID: 000002